You have 9 free searches left this month | for more free features.

thrombopoietin

Showing 1 - 25 of 222

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • eltrombopag and romiplastim
    • (no location specified)
    Nov 16, 2023

    Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

    Not yet recruiting
    • Immune Thrombocytopenia
    • Pregnancy Related
    • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
    • intravenous immunoglobulin
    • (no location specified)
    Dec 1, 2022

    Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Dec 29, 2022

    Sepsis, Thrombocytopenia Trial in Shanghai (rhTPO, Placebo)

    Recruiting
    • Sepsis
    • Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai General Hospital, Shanghai Jiaotong University
    Oct 25, 2022

    Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

    Recruiting
    • Immune Thrombocytopenia
    • Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Apr 17, 2022

    Pneumonia, Thrombocytopenia Trial (recombinant human thrombopoietin, normal saline)

    Not yet recruiting
    • Pneumonia
    • Thrombocytopenia
    • recombinant human thrombopoietin
    • normal saline
    • (no location specified)
    Jan 19, 2022

    Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

    Recruiting
    • Immune Thrombocytopenia Purpura
    • Cairo, Egypt
      EL-Kasr elineiy
    May 6, 2023

    Liver Disease Chronic, Thrombocytopenia Trial in Beijing (recombinant human thrombopoietin injection)

    Not yet recruiting
    • Liver Disease Chronic
    • Thrombocytopenia
    • recombinant human thrombopoietin injection
    • Beijing, Beijing, China
      Peking University First Hospital
    Dec 31, 2021

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Aplastic Anemia Trial in Assiut (Combination of thrombopoietin mimetic and cyclosporin A)

    Completed
    • Aplastic Anemia
    • Combination of thrombopoietin mimetic and cyclosporin A
    • Assiut, Egypt
      Assiut university hospital Internal Medicine Department Hematolo
    Sep 28, 2021

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)

    Completed
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    May 5, 2023

    Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

    Recruiting
    • Aplastic Anemia
    • +2 more
    • Beijing, China
      Peking union medical college hospital
    Aug 20, 2023

    Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • (no location specified)
    Jun 5, 2023

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Sep 21, 2022

    Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

    Recruiting
    • Immune Thrombocytopenia
    • Suzhou, Jiangsu, China
      Jie Yin
    Apr 19, 2022

    Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

    Not yet recruiting
    • Tumor Therapy-related Thrombocytopenia
    • TPO-RA (Herombopag)
    • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
    • (no location specified)
    Apr 27, 2022

    Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

    Not yet recruiting
    • Stem Cell Transplant Complications
    • Eltrombopag 25 MG Oral Tablet
    • Thrombopoietin
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 17, 2022

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)

    Not yet recruiting
    • PLT After Allogenic Hematopoietic Stem Cell Transplantation
    • (no location specified)
    Nov 21, 2021

    Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

    Active, not recruiting
    • Moderate Aplastic Anemia
    • Unilineage Bone Marrow Failure Disorders
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 2, 2021

    Eltrombopag and Recombinant Human Thrombopoietin In Primary

    Unknown status
    • Corticosteroid-resistant or Relapsed ITP
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Oct 17, 2020

    Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

    Completed
    • Anemia, Aplastic
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 30, 2020

    Cancer Treatment Induced Thrombocytopenia Trial in China (rhTPO, Control)

    Recruiting
    • Cancer Treatment Induced Thrombocytopenia
    • Anqing, Anhui, China
    • +17 more
    Jan 3, 2023